The evidence for the utility of MPAC's is quite impressive. The safety at this dosage is well established. It's time for the FDA to do the right thing.
Five dollar threshold permits buying by more funds.
Tiny float means potentially huge moves. GLTA longs.
I just rumaged around under the seat cushions on the sofa (Disgusting! How much popcorn can my kids eat--or, fail to eat!?) and I found enough spare change to buy a few more shares. You?
If this continues, and it sure looks like it will, this will be the 4th day in a row.
And to answer copper, I'll take 12% EVERY day.
Even though I am an American, when Prana does get around to making their next significant news announcement--the data submission to the FDA to end the PCH, or publication of results from Tanzi's alzheimer's-in-a-dish, or the regulatory submission to enable first-in-man studies of PBT434 in Parkinson's, etc.......... I'm OK with them waiting (the SEC gives them 72 hours, I think, for material events)and giving the Aussies a full day of trading before the American markets open--I mean it only seems right, right?
Wow! That was fast. Must have been pretty good demand.
Asterias announced today the closing of its previously announced underwritten public offering of 5,147,059 shares of common stock, and warrants to purchase an aggregate of 2,573,530 shares of common stock at an exercise price of $4.37 per share. The underwriters also exercised their over-allotment option to purchase additional warrants to purchase 386,029 shares of common stock.